Commission Delegated Regulation (EU) 2017/698 of 3 February 2017 amending Delegated Regulation (EU) No 1062/2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council concerning the making available on the market and use of biocidal productsText with EEA relevance.

Commission Delegated Regulation (EU) 2017/698 of 3 February 2017 amending Delegated Regulation (EU) No 1062/2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council concerning the making available on the market and use of biocidal products (Text with EEA relevance) THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products OJ L 167, 27.6.2012, p. 1. and in particular Article 89(1) thereof, Whereas: (1) Commission Delegated Regulation (EU) No 1062/2014 Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 (OJ L 294, 10.10.2014, p. 1). sets out, in its Annex II, an exhaustive list of existing active substances/product-type combinations included in the programme of review of existing biocidal active substances on 4 August 2014. (2) According to Article 14(3) of Delegated Regulation (EU) No 1062/2014, any person could have notified a substance/product-type combination included in part 2 of Annex II thereto within 12 months from the entry into force of that Regulation. Since that deadline has passed, part 2 of Annex II and Article 14(3) of that Regulation have become obsolete and Commission Implementing Decision (EU) 2016/1950 Commission Implementing Decision (EU) 2016/1950 of 4 November 2016 on the non-approval of certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 300, 8.11.2016, p. 14). has been taken not approving these substance/product type combinations. (3) Substance/product-type combinations notified pursuant to Article 14(3) and found compliant with Article 17(2) of Delegated Regulation (EU) No 1062/2014 should be included in part 1 of Annex II to that Regulation and removed from part 2 of that Annex. (4) According to Article 16(4) of Delegated Regulation (EU) No 1062/2014, an invitation was published where any person with an interest could notify the relevant active substance/product-type combination(s). One notification pursuant to Article 16(5) of Delegated Regulation (EU) No 1062/2014 and concerning dialuminium chloride pentahydroxide for use in product-type 2, was made before the deadline and was found compliant with Article 17(2) of Delegated Regulation (EU) No 1062/2014. Therefore this substance/product-type combination has to be included in part 1 of Annex II to that Regulation. (5) The Evaluating Competent Authority should be appointed pursuant to Article 81 of Regulation (EU) No 528/2012 for the active substance/product-type combinations mentioned in recital 3 and 4.

(6) Active substance/product-type combinations for which a decision of approval or non-approval has been adopted since 4 August 2014 are no longer in the review programme, and therefore shall no longer be referred to in part 1 of Annex II to Delegated Regulation (EU) No 1062/2014. (7) The substance/product-type combinations listed in part 2 of Annex II to Delegated Regulation (EU) No 1062/2014 that were not notified pursuant to Article 14(3) of the Review Regulation should be removed from part 2 of that Annex. Part 2 of that Annex therefore becomes obsolete and should be removed. (8) Consequently, part 1 of Annex II to Delegated Regulation (EU) No 1062/2014 should become Annex II as it is the only remaining part in Annex II and references to Article 14(3) and part 1 of Annex II need to be removed. (9) Delegated Regulation (EU) No 1062/2014 should therefore be amended accordingly, HAS ADOPTED THIS REGULATION:

Article 1

Delegated Regulation (EU) No 1062/2014 is amended as follows: (1) In Article 14, paragraph 3 is deleted. (2) Article 17 is amended as follows: (a) paragraph 1 is replaced by the following:

1. Notifications pursuant to Article 14(2) or Article 16(5) shall be made to the Agency through the Register. (b) in paragraph 7, point (a) is replaced by the following: (a) where the notification has been submitted pursuant to Article 14(2), update the information in the Register with respect to the identity of the participant and, where relevant, of the substance;. (3) In Article 20 points (b) and (c) are replaced by the following: (b) where no person has submitted a notification within the time limits provided for by Article 14(2) of this Regulation, or where such a notification has been submitted and rejected pursuant to Article 17(4) or Article 17(5) thereof; (c) where a notification has been submitted within the time limits provided for by Article 14(2) of this Regulation and has been found compliant pursuant to Article 17(5) thereof, but the substance identity in the notification only covers part of the existing identity in Annex II to this Regulation.. (4) Annex II is replaced by the text set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 3 February 2017. For the Commission The President Jean-Claude Juncker

Annex

ANNEX

Annex

ANNEX II SUBSTANCE/PRODUCT-TYPE COMBINATIONS INCLUDED IN THE REVIEW PROGRAMME ON 3 FEBRUARY 2017 Active substance/product-type combinations supported on 3 February 2017 excluding any other nanomaterial than those explicitly mentioned in entries 1017, 1019 and 1023 Entry numberSubstance nameRapporteur Member StateEC numberCAS number1234567891011121317181921221FormaldehydeDE200-001-850-00-0xxx62-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether (Piperonyl butoxide/PBO)EL200-076-751-03-6x9BronopolES200-143-052-51-7xxxxxx36EthanolEL200-578-664-17-5xxx37Formic acidBE200-579-164-18-6xxxxxxx43Salicylic acidNL200-712-369-72-7xxx45Propan-1-olDE200-746-971-23-8xxx52Ethylene oxideN200-849-975-21-8x60Citric acidBE201-069-177-92-9x69Glycolic acidNL201-180-579-14-1xxx70Peracetic acidFI201-186-879-21-0xx71L-(+)-lactic acidDE201-196-279-33-4xxxx79(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one (Rotenone)UK201-501-983-79-4x

85SymcloseneUK201-782-887-90-1xxxxxx92Biphenyl-2-olES201-993-590-43-7xxx113Cinnamaldehyde/3-phenyl-propen-2-al (Cinnamic aldehyde)UK203-213-9104-55-2x117GeraniolFR203-377-1106-24-1xx122GlyoxalFR203-474-9107-22-2xxx133Hexa-2,4-dienoic acid (Sorbic acid)DE203-768-7110-44-1x154Clorophene (Chlorophene)N204-385-8120-32-1xx1712-PhenoxyethanolUK204-589-7122-99-6xxxxx172Cetylpyridinium chlorideUK204-593-9123-03-5x179Carbon dioxideFR204-696-9124-38-9x180Sodium dimethylarsinate (Sodium Cacodylate)PT204-708-2124-65-2x185Tosylchloramide sodium (Tosylchloramide sodium — Chloramin T)ES204-854-7127-65-1xxxx187Potassium dimethyldithiocarbamateUK204-875-1128-03-0xxx188Sodium dimethyldithiocarbamateUK204-876-7128-04-1xxx195Sodium 2-biphenylateES205-055-6132-27-4xxxxxxxxx206ThiramBE205-286-2137-26-8x 210Metam-sodiumBE205-293-0137-42-8xx2272-thiazol-4-yl-1H-benzoimidazole (Thiabendazole)ES205-725-8148-79-8xxx235DiuronDK206-354-4330-54-1xx239CyanamideDE206-992-3420-04-2xx253Tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione (Dazomet)BE208-576-7533-74-4xx283TerbutrynSK212-950-5886-50-0xxx288N-(Dichlorofluoromethylthio)-N′,N′-dimethyl-N-phenylsulfamide (Dichlofluanid)UK214-118-71085-98-9xx292(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (d-Tetramethrin)DE214-619-01166-46-7x321MonolinuronUK217-129-51746-81-2x330N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine (Diamine)PT219-145-82372-82-9xxxxxxxx3362,2′-dithiobis[N-methylbenzamide] (DTBMA)PL219-768-52527-58-4x3391,2-benzisothiazol-3(2H)-one (BIT)ES220-120-92634-33-5xxxxxx3412-methyl-2H-isothiazol-3-one (MIT)SI220-239-62682-20-4xxx 346Sodium dichloroisocyanurate dihydrateUK220-767-751580-86-0xxxxxx345Troclosene sodiumUK220-767-72893-78-9xxxxxx348Mecetronium ethyl sulphate (MES)PL221-106-53006-10-8x359(ethylenedioxy)dimethanol (Reaction products of ethylene glycol with paraformaldehyde (EGForm))PL222-720-63586-55-8xxxxx365Pyridine-2-thiol 1-oxide, sodium salt (Sodium pyrithione)SE223-296-53811-73-2xxxxxxx368Methenamine 3-chloroallylochloride (CTAC)PL223-805-04080-31-3xxx3772,2′,2′-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol (HHT)PL225-208-04719-04-4xxxx382Tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dione (TMAD)ES226-408-05395-50-6xxxxx392Methylene dithiocyanateFR228-652-36317-18-6x3931,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione (DMDMH)PL229-222-86440-58-0xx397Didecyldimethylammonium chloride (DDAC)IT230-525-27173-51-5xxxxxxxx 401SilverSE231-131-37440-22-4xxxxx1023Silver, as a nanomaterialSE231-131-37440-22-4xxx405Sulphur dioxideDE231-195-27446-09-5x424Sodium bromideNL231-599-97647-15-6xxx432Sodium hypochloriteIT231-668-37681-52-9xxxxxxx434TetramethrinDE231-711-67696-12-0x439Hydrogen peroxideFI231-765-07722-84-1xx4447a-ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole (EDHO)PL231-810-47747-35-5xx450Silver nitrateSE231-853-97761-88-8x453Disodium peroxodisulphate/Sodium persulphatePT231-892-17775-27-1x455Calcium hypochloriteIT231-908-77778-54-3xxxxx457ChlorineIT231-959-57782-50-5xxx458Ammonium sulphateUK231-984-17783-20-2xx1016Silver chlorideSE232-033-37783-90-6xxxxxxx473Pyrethrins and PyrethroidsES232-319-88003-34-7xx491Chlorine dioxidePT233-162-810049-04-4xxxxxx4942,2-dibromo-2-cyanoacetamide (DBNPA)DK233-539-710222-01-2xxxxxx501CarbendazimDE234-232-010605-21-7xxx

1022Dialuminium chloride pentahydroxideNL234-933-112042-91-0x515Ammonium bromideSE235-183-812124-97-9xx522Pyrithione zinc (Zinc pyrithione)SE236-671-313463-41-7xxxxxx524Dodecylguanidine monohydrochlorideES237-030-013590-97-1xx526Potassium 2-biphenylateES237-243-913707-65-8xxxx529Bromine chlorideNL237-601-413863-41-7x531(benzyloxy)methanolUK238-588-814548-60-8xx541Sodium p-chloro-m-cresolateFR239-825-815733-22-9xxxxxx550D-gluconic acid, compound with N,N′-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine (2:1) (CHDG)PT242-354-018472-51-0xxx554p-[(diiodomethyl)sulphonyl]tolueneUK243-468-320018-09-1xxxx559(benzothiazol-2-ylthio)methyl thiocyanate (TCMTB)N244-445-021564-17-0xx5622-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Prallethrin)EL245-387-923031-36-9x 563Potassium (E,E)-hexa-2,4-dienoate (Potassium Sorbate)DE246-376-124634-61-5x566.alpha.,.alpha.′,.alpha.′-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol (HPT)AT246-764-025254-50-6xxxx5712-octyl-2H-isothiazol-3-one (OIT)UK247-761-726530-20-1xxxxxx577Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chlorideES248-595-827668-52-6xxx588Bromochloro-5,5-dimethylimidazolidine-2,4-dione (BCDMH/Bromochlorodimethylhydantoin)NL251-171-532718-18-6xxx5903-(4-isopropylphenyl)-1,1-dimethylurea/IsoproturonDE251-835-434123-59-6xx5971-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole (Imazalil)DE252-615-035554-44-0x599S-[(6-chloro-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl] O,O-dimethyl thiophosphate (Azamethiphos)UK252-626-035575-96-3x606.alpha.-cyano-3-phenoxybenzyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Cyphenothrin)EL254-484-539515-40-7x608Dimethyltetradecyl[3-(trimethoxysilyl)propyl]ammonium chloridePL255-451-841591-87-1x 609Mixture of cis- and trans-p-menthane-3,8 diol (Citriodiol)UK255-953-742822-86-6x614(RS)-α-cyano-3phenoxybenzyl-(1RS)- cis,trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (Cypermethrin)BE257-842-952315-07-8x6181-ethynyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Empenthrin)BE259-154-454406-48-3x6193-iodo-2-propynylbutylcarbamate (IPBC)DK259-627-555406-53-6xxx620Tetrakis(hydroxymethyl)phosphonium sulphate(2:1) (THPS)MT259-709-055566-30-8xxxx6484,5-Dichloro-2-octylisothiazol-3(2H)-one (4,5-Dichloro- 2-octyl-2H- isothiazol-3-one (DCOIT))N264-843-864359-81-5xxxx6563,3′-methylenebis[5-methyloxazolidine] (Oxazolidin/MBO)AT266-235-866204-44-2xxxxx667Alkyl (C12-18) dimethylbenzyl ammonium chloride (ADBAC (C12-18))IT269-919-468391-01-5xxxxxxxx671Alkyl (C12-16) dimethylbenzyl ammonium chloride (ADBAC/BKC (C12-C16))IT270-325-268424-85-1xxxxxxxx 673Didecyldimethylammonium chloride (DDAC (C8-10))IT270-331-568424-95-3xxxxxxxxx690Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, salts with 1,2-benzisothiazol-3(2H)-one 1,1-dioxide (1:1) (ADBAS)MT273-545-768989-01-5xx691Sodium N-(hydroxymethyl)glycinateAT274-357-870161-44-3x692Amines, C10-16-alkyldimethyl, N-oxidesPT274-687-270592-80-2x693Pentapotassium bis(peroxymonosulphate) bis(sulphate)SI274-778-770693-62-8xxxx701Magnesium monoperoxyphthalate hexahydrate (MMPP)PL279-013-084665-66-7x1015Margosa extractDE283-644-784696-25-3x1024Margosa extract from cold-pressed oil of the kernels of Azadirachta Indica extracted with super-critical carbon dioxideDE283-644-784696-25-3x724Alkyl (C12-C14) dimethylbenzylammonium chloride (ADBAC (C12-C14))IT287-089-185409-22-9xxxxxxxx725Alkyl (C12-C14) dimethyl(ethylbenzyl)ammonium chloride (ADEBAC (C12-C14))IT287-090-785409-23-0xxxxxxxx

731Chrysanthemum cinerariaefolium, ext.ES289-699-389997-63-7x744Lavender, Lavandula hybrida, ext./Lavandin oilPT294-470-691722-69-9x779Reaction products of: glutamic acid and N-(C12-C14-alkyl)propylenediamine (Glucoprotamin)DE403-950-8164907-72-6xx7856-(phthalimido)peroxyhexanoic acid (PAP)IT410-850-8128275-31-0xxxx7912-butyl-benzo[d]isothiazol-3-one (BBIT)CZ420-590-74299-07-4xxxxx792Tetrachlorodecaoxide complex (TCDO)DE420-970-292047-76-2xxx811Silver sodium hydrogen zirconium phosphateSE422-570-3265647-11-8xxxxx794sec-butyl 2-(2-hydroxyethyl)piperidine-1-carboxylate/Icaridine (Icaridine)DK423-210-8119515-38-7x797cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis CTAC)PL426-020-351229-78-8xx800[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate;[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate (Imiprothrin)UK428-790-672963-72-5x 807(E)-1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine (Clothianidin)DE433-460-1210880-92-5952Bacillus sphaericus other than Bacillus sphaericus 2362, strain ABTS-1743ITMicro-organism143447-72-7x955Bacillus thuringiensis subsp.israelensis Serotype H14, other than strain AM65-52 and other than strain SA3AITMicro-organismNot applicablex957Bacillus subtilisDEMicro-organismNot applicablex939Active Chlorine: manufactured by the reaction of hypochlorous acid and sodium hypochlorite produced in situSKMixtureNot applicablexxxx813Peroxyoctanoic acidFRNot applicable33734-57-5xxx1014Silver zeoliteSENot applicableNot applicablexxxxx152Reaction products of 5,5-dimethylhydantoin, 5-ethyl-5-methylhydantoin with bromine and chlorine (DCDMH)NLNot availableNot availablex459Reaction mass of titanium dioxide and silver chlorideSENot availableNot availablexxxxxxx777Reaction products of 5,5-dimethylhydantoin, 5-ethyl-5-methylhydantoin with chlorine (DCEMH)NLNot availableNot availablex 810Silver phosphate glassSENot available308069-39-8xxx824Silver zinc zeoliteSENot available130328-20-0xxxxx1013Silver copper zeoliteSENot available130328-19-7xxxxx1017Silver adsorbed on silicon dioxide (as a nanomaterial in the form of a stable aggregate with primary particles in the nanoscale)SENot availableNot availablex1019Silicon dioxide (as a nanomaterial formed by aggregates and agglomerates)FRNot available68909-20-6x831Silicium dioxide (Silicium dioxide/Kieselguhr)FRPlant protection product61790-53-2x854(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R;1R,3S)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 4 isomers 1R trans, 1R: 1R trans, 1S: 1R cis, 1R: 1R cis, 1S 4:4:1:1) (d-Allethrin)DEPlant protection product231937-89-6x855(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers 1R trans: 1R/S only 1:3) (Esbiothrin)DEPlant protection product260359-57-7x 848N-((6-Chloro-3-pyridinyl)methyl)-N′-cyano-N-methylethanimidamide (Acetamiprid)BEPlant protection product160430-64-8x835Esfenvalerate/(S)-.alpha.-Cyano-3-phenoxybenzyl (S)-2-(4-chlorophenyl)-3-methylbutyrate (Esfenvalerate)PTPlant protection product66230-04-4x8434-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile (Chlorfenapyr)PTPlant protection product122453-73-0x859Polymer of N-Methylmethanamine (Einecs 204-697-4 with (chloromethyl)oxirane (Einecs 203-439-8)/Polymeric quaternary ammonium chloride (PQ Polymer)HUPolymer25988-97-0xx863Monohydro chloride of polymer of N,N″-1,6-hexanediylbis[N′-cyanoguanidine] (Einecs 240-032-4) and hexamethylenediamine (Einecs 204-679-6)/Polyhexamethylene biguanide (monomer: 1,5-bis(trimethylen)-guanylguanidinium monohydrochloride) (PHMB)FRPolymer27083-27-8/32289-58-0x868Poly(hexamethylenebiguanide)FRPolymer91403-50-8xxxxxxxx869Poly(oxy-1,2-ethanediyl),.alpha.-[2-(didecylmethylammonio)ethyl]-.omega.-hydroxy-, propanoate (salt) (Bardap 26)ITPolymer94667-33-1xxx